| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5941128 | The Annals of Thoracic Surgery | 2006 | 6 Pages |
Abstract
Coronary artery surgery patients benefit from L-arginine cardioplegia supplementation in terms of reduced inflammatory reaction, limitation of myocardial ischemia, and better hemodynamic performance. Moreover, a clinical advantage is evident in terms of a shorter intensive care unit stay in patients treated with L-arginine.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luisa MD, PhD, Francesco MD, Fabiano MD, Antonello MD, Fabio MD, Leonello MD, Giovanni MD, PhD,